Aromatase inhibition for ovarian stimulation: future avenues for infertility management
Authors:
- Robert F. CasperRCRobert F. Casper
- 1 June 2002
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Obstetrics and Gynecology
- Vol. 14 (3) , 255-263
Abstract
Ovarian stimulation is applied during infertility management either alone or in conjunction with intrauterine insemination and assisted reproductive technologies. At the present time, the two main medications used for ovarian stimulation include an oral antiestrogen, clomiphene citrate, and injectable gonadotropins. In spite of the high ovulation rate with the use of clomiphene citrate, the pregnancy rate is much lower. In clomiphene citrate failures, gonadotropin injections have generally been used as the next treatment option. Treatment with gonadotropins is difficult to control and characteristically associated with increased risk of severe ovarian hyperstimulation syndrome and high multiple pregnancies. Therefore, an effective oral treatment that could be used without risk of hyperstimulation and with minimal monitoring is the preferred therapy. We hypothesize that aromatase inhibitors can be administered early in the follicular phase to induce ovulation by releasing the hypothalamus or pituitary from estrogen negative feedback. Based on this hypothesis, we have reported the success of aromatase inhibitors in induction and augmentation of ovulation in addition to improving ovarian response to gonadotropin stimulation. Moreover, there are other potential applications for aromatase inhibitors in infertility management, including improving implantation in assisted reproduction and in-vitro maturation.Keywords
This publication has 107 references indexed in Scilit:
- Sex- and Age-Related Response to Aromatase Deficiency in BoneBiochemical and Biophysical Research Communications, 2001
- Effects of Tamoxifen (Tx) on Endometrial Thickness and Pregnancy Rates in Women Undergoing Superovulation with Clomiphene Citrate (CC) and Intrauterine Insemination (IUI)Fertility and Sterility, 2000
- Disruption of Sexual Behavior in Male Aromatase-Deficient Mice Lacking Exons 1 and 2 of thecyp19GeneBiochemical and Biophysical Research Communications, 1998
- Aromatase Deficiency in a Female Who Is Compound Heterozygote for Two New Point Mutations in the P450arom Gene: Impact of Estrogens on Hypergonadotropic Hypogonadism, Multicystic Ovaries, and Bone Densitometry in ChildhoodThe Journal of Clinical Endocrinology & Metabolism, 1997
- Exogenous Estrogen Therapy Concurrent with Clomiphene Citrate-Lack of Effect on Serum Sex Hormone Levels and Endometrial ThicknessGynecologic and Obstetric Investigation, 1994
- Interface between Extra‐ and Intraovarian Factors in Polycystic Ovarian SyndromeAnnals of the New York Academy of Sciences, 1993
- A prospective, randomised, cross-over study comparing the effects of clomiphene citrate and cyclofenil on endometrial morphology in the luteal phase of normal, fertile womenBJOG: An International Journal of Obstetrics & Gynaecology, 1992
- Ovarian hyperstimulation syndrome: A review of pathophysiologyJournal of Assisted Reproduction and Genetics, 1992
- Medical and surgical adrenalectomy in patients with advanced breast carcinomaCancer, 1977
- Critical Review of 160 Clomiphenerelated PregnanciesObstetrics & Gynecology, 1968